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Abstract
Objectives
To compare 10-minute (min) delayed hepatocyte phase imaging (HPI) using a 30˚ flip angle
(FA) (10m-FA30) and 20-min delayed HPI using a 10˚ FA (20m-FA10) or 30˚ FA (20m-
FA30) in Gd-EOB-DTPA-enhanced MRI in patients with chronic hepatitis or cirrhosis, in
terms of lesion-to-liver contrast-to-noise ratio (CNR) for hepatocellular carcinoma (HCC)
and detection sensitivity for focal hepatic lesions (FHLs).
Materials and Methods
One hundred and four patients with 168 HCCs and 55 benign FHLs who underwent Gd-
EOB-DTPA-enhanced MRI with 10m-FA30, 20m-FA10, and 20m-FA30 were enrolled.
Patients were divided into two groups according to the Child-Pugh classification: group A
with chronic hepatitis or Child-Pugh A cirrhosis and group B with Child-Pugh B or C cirrhosis.
Lesion-to-liver CNR for HCCs was compared between 10m-FA30 and 20m-FA10 or 20m-
FA30 for each group. The presence of FHLs was evaluated using a four-point scale by two
independent reviewers, and the detection sensitivity was analyzed.
Results
In group A, the CNR for HCCs (n = 86) on 10m-FA30 (165.8 ± 99.7) was significantly higher
than that on 20m-FA10 (113.4 ± 71.4) and lower than that of 20m-FA30 (210.2 ± 129.3).
However, there was no significant difference in the sensitivity of FHL detection between
10m-FA30 (mean 95.0% for two reviewers) and 20m-FA10 (94.7%) or 20m-FA30 (94.7%).
In group B, the CNR (54.0 ± 36.4) for HCCs (n = 57) and the sensitivity (94.2%) of FHL
detection for 10m-FA30 were significantly higher than those for 20m-FA10 (41.8 ± 36.4 and
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80.8%, respectively) and were not different from those for 20m-FA30 (62.7 ± 44.4 and
93.3%, respectively).
Conclusion
The diagnostic performance of 10m-FA30 was similar to or higher than 20m-FA10 or 20m-
FA30 in both groups A and B. This finding indicates that 10m-FA30 could replace 20-min
delayed HPI regardless of patient liver function and reduce the delay time by 10 minutes.
Introduction
Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) is a liver-spe-
cific contrast agent for magnetic resonance imaging (MRI) that provides both dynamic imag-
ing and static hepatocyte-specific imaging. Recent reports show that Gd-EOB-DTPA–
enhanced MRI is highly sensitive for the detection of focal hepatic lesions (FHLs) such as hepa-
tocellular carcinomas (HCCs) and metastatic tumors [1–3]. However, sufficient enhancement
of liver parenchyma on hepatocyte phase imaging (HPI) from adequate Gd-EOB-DPTA
uptake by hepatocytes is necessary to detect FHLs [4]. HPI is usually obtained 20-minute
(min) after intravenous injection of Gd-EOB-DTPA [1, 5–7]. Several studies have tried to
reduce the delay time for HPI after contrast injection [8–11] because decreasing this delay
time would increase patient throughput and reduce patient discomfort during MRI scanning
[11]. Ten-min delayed HPI may be sufficient for detection and characterization of FHLs, but
has a significantly lower signal ratio or lesion-to-liver contrast-to-noise ratio (CNR) than
20-min delayed HPI [8, 10].
HPI has commonly been obtained using a T1-weighted (T1w) three-dimensional (3D) gra-
dient echo (GRE) sequence with a flip angle (FA) of 10–15˚ to match the FA used for dynamic
sequences [12, 13]. However, several studies suggest that using a higher FA of 30–40˚ improves
detection, conspicuity, and lesion-to-liver CNR for FHLs [14–17] because a higher FA
increases the T1-weighting [14]. Recent studies have introduced the possibility of reducing the
delay time for HPI without loss of CNR by applying higher FA [18, 19]. Five-min or 10-min
delayed imaging with 30˚ FA (5m-FA30 or 10m-FA30, respectively) yields higher CNR and
similar detection sensitivity for FHL compared to 20-min delayed HPI with 10˚ FA (20m-
FA10). Interestingly, the CNR for HCCs was found to be significantly higher on 5m-FA30
than on 20m-FA10 [18], but lesion-to-liver CNR according to liver function was not evaluated.
The hepatic uptake of Gd-EOB-DTPA is related to the severity of cirrhosis [20–22].
We hypothesized that 10-min delayed HPI using a high FA of 30˚ would have similar or
better diagnostic performance for HCC compared with conventional 20-min delayed HPI,
regardless of the degree of liver cirrhosis. We speculated that 10 minutes of delay for HPI
would be sufficient for adequate hepatic uptake of Gd-EOB-DTPA in patients with chronic
hepatitis or compensated cirrhosis, and noted that patients with decompensated cirrhosis dis-
play no more Gd-EOB-DTPA uptake after 10 minutes in delay time [20–22]. Therefore, we
divided enrolled patients into compensated and decompensated liver disease groups [23], and
compared the CNR for HCCs and detection sensitivity for FHLs between 10m-FA30 and 20m-
FA10 for each subgroup. In addition, the values between 10m-FA30 and 20-min delayed HPI
with 30˚ FA (20m-FA30) were compared. The final aim of our study was to determine whether
the 10m-FA30 protocol could replace 20-min delayed HPI in patients with chronic hepatitis or
cirrhosis, based on CNR of HCCs and detection sensitivity for FHLs.
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Materials and Methods
The Gangnam Severance Hospital institutional review board (IRB) approved this retrospective
study and written informed consent was waived. Patient records were anonymized and de-
identified prior to analysis.
Patient Population and Standard Reference
From May 2012 to November 2014, 124 consecutive patients with suspected or known HCC
underwent a Gd-EOB-DTPA-enhanced liver MRI. Twenty patients were excluded from the
study because of an unknown final diagnosis owing to the lack of a valid reference standard
(n = 15) and duplicate MRI examinations of the same patients (n = 5). Therefore, a total of 104
with 168 HCCs and 55 benign FHLs were analyzed (Table 1).
The final diagnostic criteria for all 168 HCCs (mean size ± standard deviation, 2.3 ± 1.7 cm;
range, 0.6–9.0 cm) were as follows: pathologically proven (n = 22 by resection and n = 1 by
biopsy), tumor staining on transarterial chemoembolization (TACE) with sustained iodized-
oil accumulation on follow-up CT (n = 130), and typical findings on dynamic imaging (arterial
hypervascularity and portal venous/delayed phase washout on dynamic CT and/or arterial
hypervascularity and portal venous phase washout on dynamic MRI) (n = 15).
Among the 55 benign lesions, one cirrhotic nodule was diagnosed pathologically after liver
transplantation. Diagnosis of the remaining 54 lesions, including 19 cysts (0.8 ± 0.4 cm; 0.4–
1.8 cm), 15 hemangiomas (0.9 ± 0.5 cm; 0.4–2.3 cm), and 21 dysplastic or cirrhotic nodules
(1.5 ± 0.6 cm; 0.8–2.8 cm), was established based on well-confirmed characteristic imaging cri-
teria and non-progressive appearance in size on follow-up imaging studies, which included
examinations before the present study period [24–27].
Table 1. Patient Clinical Information and Focal Hepatic Lesion Characteristics.
Mean age (age range) 61 (44–81)
Sex (M/F) 85/19
Diagnosis of FHLs HCC 168
Benign Cyst 19
Hemangioma 15
DN/CN 21
Size of FHLs Large HCC 143
Benign 30
Small HCC 25
Benign 25
Background liver Chronic hepatitis Hepatitis B virus 16
Hepatitis C virus 2
Non-B and non-C 3
Cirrhosis Hepatitis B virus 59
Hepatitis C virus 9
Alcoholic 3
Non-B and non-C 12
Child-Pugh classification A 78
B 21
C 5
FHLs = focal hepatic lesions; HCC = hepatocellular carcinoma; DN/CN = dysplastic/cirrhotic nodule; Large = focal hepatic lesions 10 mm or greater in short
axis; Small = focal hepatic lesions less than 10 mm in short axis; Non-B/C = non-B and non-C viral.
doi:10.1371/journal.pone.0167701.t001
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Pathologic specimens were used in 34 patients to confirm chronic hepatitis (n = 1 by biopsy
and n = 14 by surgical specimen) and cirrhosis (n = 2 by biopsy and n = 17 by surgical speci-
men). Chronic hepatitis or cirrhosis of the other 70 patients was diagnosed by imaging find-
ings using ultrasonography, CT, and MRI (liver surface irregularity, marginal dullness,
atrophy of the right lobe and segment 4 of liver, hypertrophy of the left lobe and caudate lobe
of liver, splenomegaly, and development of collateral veins), with referring blood examinations
(prothrombin time, platelet counts, alanine aminotransferase, and aspartate aminotransferase)
[20, 28–32]. Etiology of chronic hepatitis or cirrhosis is presented in Table 1.
Patients with chronic hepatitis or cirrhosis were classified into two groups according to the
Child-Pugh classification: group A with chronic hepatitis or compensated liver cirrhosis
(Child-Pugh class A) or group B with decompensated liver cirrhosis (Child-Pugh B or C) [23].
MR Image Protocol
All studies were conducted using a 1.5 T MR scanner (Magnetom Avanto; Siemens Medical
Solutions, Erlangen, Germany). For all patients, 3D axial fat suppressed T1w volumetric inter-
polated breath-hold examination (VIBE) images were acquired for dynamic imaging along
with 10-min or 20-min delayed HPI after the administration of Gd-EOB-DPTA. A 30˚ FA was
used for 10-min delayed HPI and both 10˚ and 30˚ FAs were used for 20-min delayed HPI.
The other VIBE imaging parameters were as follows: repetition time (TR)/echo time (TE) of
5.1/2.4 msec, slice thickness of 2.8 mm, matrix of 256 x 179, number of excitations of 1,
receiver bandwidth of 300 Hz/pixel, integrated parallel imaging techniques (iPAT) using accel-
eration factors of 2, k-space trajectory of rectangular (10˚ FA) and central (30˚ FA) ordering of
the echo train following a spectral fat suppression pulse, and an acquisition time of 14–15 sec-
onds at either 10˚ FA or 30˚ FA imaging. A dose of 0.025 mmol/kg of Gd-EOB-DTPA (Primo-
vist, Bayer Schering Pharma, Berlin, Germany) was injected at a rate of 1 mL/s using a power
injector (MedRad Spectris Solaris EP, Medrad, Indianola, PA, USA) through a 20-gauge cathe-
ter inserted into the veins of the antecubital area, followed by 20 mL of normal saline at the
same injection rate. All MR images were sent to a picture archive and communication systems
(PACS) workstation (Centricity RA1000, GE Healthcare, Milwaukee, USA) for image analysis.
Quantitative Analysis
All HCCs were divided into two groups by size: small HCCs (<10 mm in the short-axis) or
large HCCs (10 mm in the short-axis). The short-axis diameter of each tumor was measured
on the 20m-FA10. Quantitative analysis was performed by a radiologist with three years of
liver MRI experience. The signal intensity (SI) of the liver parenchyma and each HCC were
measured on three HPIs (10m-FA30, 20m-FA10 and 20m-FA30). Background image noise
was measured ventral to the liver outside of the patient’s body. All measurements were
repeated three times for each image, and the mean value was used for assessment of the lesion-
to-liver CNR as follows: CNR = (SILiver—SIHCC)/SDNoise, where SILiver is the mean SI of the
liver parenchyma, SIHCC is the mean SI of HCC, and SDNoise is the mean standard deviation of
the background image noise.
Qualitative Analysis
The three HPIs (10m-FA30, 20m-FA10 and 20m-FA30) were independently and randomly
evaluated by two radiologists with 18 years and 9 years of experience in liver MRI. Three
image review sessions were spaced 3–4 weeks apart to prevent memory recall bias. All images
were assessed on PACS using an optimal window setting. The reviewers evaluated the presence
of FHL using a four-point scale as follows: 1 = definitely absent, 2 = probably absent,
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3 = probably present, 4 = definitely present. The reviewers marked FHLs using arrows and
scales on PACS and a coordinator with three years of liver MRI experience matched them to
the reference standard.
Statistical Analysis
Statistical analyses were performed using standard statistical software (SPSS Version 21; IBM
SPSS Statistics, IBM Corporation, Chicago, IL, USA). For the calculation of detection sensitivi-
ties for all FHLs, scores of 1 and 2 were considered negative and scores of 3 and 4 were
regarded as positive. The McNemar test was used to compare the detection sensitivities for
FHLs between 10m-FA30 and 20m-FA10 or 20m-FA30. The paired t-test was used to compare
the lesion-to-liver CNR for large HCCs (10 mm in the short-axis) between 10m-FA30 and
20m-FA10 or 20m-FA30 and the image noise between 20m-FA10 and 20m-FA30. The patients
were divided into groups A and B according to the Child-Pugh classification [23], and sub-
group analysis was conducted as well. The correlations of between lesion-to-liver CNR for
HCCs and Child-Pugh or Model for End-Stage Liver Disease (MELD) scores were analyzed
using the Pearson correlation coefficient.
For both the McNemar test and paired t-test, the Bonferroni corrected p value was applied
and a p-value of< 0.025 (= 0.05/2) was considered statistically significant. Inter-reader agree-
ment was assessed using Cohen’s kappa coefficient, which was interpreted according to the
guidelines of Landis and Koch [21].
Results
The lesion-to-liver CNRs on the three HPIs are presented in Table 2 and Fig 1. The CNR for
all HCCs in patients for 10m-FA30 (130.6 ± 99.6) was significantly higher than for 20m-FA10
(90.9 ± 70.8), but significantly lower than for 20m-FA30 (163.5 ± 129.7). In group A, the CNR
of HCCs for 10m-FA30 (165.8 ± 99.7) was also significantly higher than for 20m-FA10
(113.4 ± 71.4) and lower than for 20m-FA30 (210.2 ± 129.3) (Fig 2). In group B, the CNR of
HCCs for 10m-FA30 images (54.0 ± 36.4) was significantly higher than that for 20m-FA10
(41.8 ± 36.4), but there was no significant difference in the CNR between 10m-FA30 images
and 20m-FA30 images (62.7 ± 44.4) (Fig 3). The lesion-to-liver CNR of group A was signifi-
cantly higher than that of group B for each image group (p< 0.001).
There were negative relationships between the CNR of HCCs and Child-Pugh or MELD
scores for the three HPIs (Fig 4). Pearson correlation coefficients between CNR and Child-
Pugh score were as follows: r = - 0.491 (p< 0.001) for 10m-FA30; r = - 0.446 (p< 0.001) for
20m-FA10; and r = - 0.503 (p< 0.001) for 20m-FA30. Pearson correlation coefficients between
Table 2. Mean Lesion-to-liver Contrast-to-Noise Ratio (CNR) on 10-minute Delayed Hepatocyte Phase Imaging (HPI) using a 30˚ Flip Angle (FA)
(10m-FA30), 20-minute Delayed HPI using a 10˚ FA (20m-FA10), and 20-minute Delayed HPI using a 10˚ FA (20m-FA10).
Lesion-to-liver contrast-to-noise ratio (CNR)
10m-FA30 20m-FA10 ap value 20m-FA30 bp value
All HCCs 130.6 ± 99.6 90.9 ± 70.8 < 0.001 163.5 ± 129.7 < 0.001
HCCs in group A 165.8 ± 99.7 113.4 ± 71.4 < 0.001 210.2 ± 129.3 < 0.001
HCCs in group B 54.0 ± 36.4 41.8 ± 36.4 = 0.002 61.7 ± 44.4 = 0.158
Group A = patients with chronic hepatitis or compensated liver cirrhosis (Child-Pugh A). Group B = patients with decompensated liver cirrhosis (Child-Pugh
B or C).
a Paired t-test between 10m-FA30 and 20m-FA10,
b paired t-test between 10m-FA30 and 20m-FA30. The Bonferroni corrected p value of < 0.025 (= 0.05 / 2) is considered statistically significant.
doi:10.1371/journal.pone.0167701.t002
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CNR and MELD score were as follows: r = - 0.378 (p< 0.001) for 10m-FA30; r = - 0.304
(p< 0.001) for 20m-FA10; and r = - 0.393 (p< 0.001) for 20m-FA30. Paired t-tests showed
there was no significant difference in noise between on 20m-FA10 and on 20m-FA30
(p value = 0.295) (Fig 5).
Fig 1. Lesion-to-liver contrast-to-noise ratio (CNR) for HCCs. Box-and-whisker plots showing the median (middle line of
each box), quartiles (top and bottom lines of each box), and upper and lower adjacent (upper and lower whiskers for each
box) values of the lesion-to-liver contrast-to-noise ratio (CNR) for HCCs. HCCs were imaged according to three different
protocols: 10-minute delayed hepatocyte phase imaging (HPI) with a 30˚ flip angle (10m-FA30), 20-minute delayed HPI with
a 10˚ flip angle (20m-FA10) or a 30˚ flip angle (20m-FA30). The CNR for HCCs on 10m-FA30 was significantly higher than
that on 20m-FA10 and significantly lower than that on 20m-FA10, in both all patients and those just in group A (with chronic
hepatitis or Child-Pugh A cirrhosis). In group B with Child-Pugh B or C cirrhosis, the CNR for HCCs on 10m-FA30 was
significantly higher than that on 20m-FA10 and was not different from that on 20m-FA30.
doi:10.1371/journal.pone.0167701.g001
Fig 2. A 61-year-old man with HCC and hepatitis B-related compensated liver cirrhosis (Child-Pugh
score 5). Hepatocyte phase imaging (HPI) were acquired using 30˚ flip angle (FA) at 10-minute delayed time
(10m-FA30) (A), 10˚ FA at 20-minute delayed time (20m-FA10) (B), and 30˚ FA at 20-minute delayed time
(20m-FA30) (C) after Gd-EOB-DTPA administration. These images are viewed at the same window level
(400) and width (700). HCC in segment 8 appears as low signal intensity related to the surrounding liver
parenchyma on all three HPIs (arrow). Lesion-to-liver CNRs on 10m-FA30, 20m-FA10, and 20m-FA30 were
222.8, 147.5, and 343.1, respectively. The two reviewers’ mean subjective scores for the presence of focal
hepatic lesions were 4 (4 and 4) on all three HPIs.
doi:10.1371/journal.pone.0167701.g002
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Fig 3. A 76-year-old woman with HCC and hepatitis C-related decompensated liver cirrhosis (Child-
Pugh score 8). Hepatocyte phase imaging (HPI) were acquired using 30˚ flip angle (FA) at 10-minute delayed
time (10m-FA30) (A), 10˚ FA at 20-minute delayed time (20m-FA10) (B), and 30˚ FA at 20-minute delayed
time (20m-FA30) (C) after Gd-EOB-DTPA administration. These images are viewed at the same window level
(400) and width (700). HCC in segments 5/6 appears as low signal intensity related to the surrounding liver
parenchyma on all three HPIs (arrow). Lesion-to-liver CNRs on 10m-FA30, 20m-FA10, and 20m-FA30 were
35.0, 12.2, and 59.6, respectively. The two reviewers’ mean subjective scores for the presence of a focal
hepatic lesion were 4 (4 and 4) on both 10m-FA30 and 20m-FA30 and 2 (2 and 2) on 20m-FA10.
doi:10.1371/journal.pone.0167701.g003
Fig 4. Lesion-to-liver contrast-to-noise ratio (CNR) for HCCs according to Child-Pugh and MELD
scores. The relationships between CNR and Child-Pugh score (A) are as follows: y = -27.2x + 300.3 (r =
- 0.491) for 10m-FA30, y = -17.5x + 200.5 (r = - 0.446) for 20m-FA10; and y = -36.3x + 390.1 (r = - 0.503) for
20m-FA30. The relationships between CNR and MELD score (B) are as follows: y = -8.4x + 217.3 (r = - 0.378)
for 10m-FA30; y = -4.8x + 140.5 (r = - 0.304) for 20m-FA10; and y = -11.4x + 281.1 (r = - 0.393) for 20m-FA30.
doi:10.1371/journal.pone.0167701.g004
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Detection sensitivities for FHLs on the three HPIs are summarized in Table 3. In all patients
(both group A and B), the detection sensitivities for all FHLs, large FHLs (10 mm in the
short-axis) and HCCs for 10m-FA30 were significantly higher than for 20m-FA10 for reader
A. The detection sensitivity for them at 10m-FA30 for reader B tended to be higher than at
20m-FA10 although there was no statistical difference. There was no significant difference in
detection sensitivity between 10m-FA30 and 20m-FA30 for both readers. In group A, there
was no significant difference in the detection sensitivity between 10m-FA30 and 20m-FA10 or
between 10m-FA30 and 20m-FA30 for both readers, irrespective of the lesions’ malignancy or
benignity and the size of the FHLs. In group B, the detection sensitivities for all FHLs, large
FHLs (10 mm in the short-axis) and HCCs for 10m-FA30 were significantly higher than for
20m-FA10. However, there was no significant difference in detection sensitivity between 10m-
FA30 and 20m-FA30.
The interobserver agreement was almost perfect for both readers (kappa value = 0.860).
Discussion
In patients with compensated or decompensated liver disease, 10m-FA30 was superior to
20m-FA10 in terms of CNR for HCCs or detection sensitivity for FHLs. In patients with com-
pensated liver disease, there was no significant difference in detection sensitivity between
10m-FA30 and 20m-FA30, even though the lesion-to-liver CNR for 20m-FA30 was higher
than that for 10m-FA30. In decompensated liver disease, there was no significant difference in
lesion-to-liver CNR and detection sensitivity between 10m-FA30 and 20m-FA30.
Dynamic contrast-enhanced imaging and HPI have usually been obtained using a T1w FS
3D GRE sequence with low FA and short TR to decrease scan time. Because of the relatively
Fig 5. The correlation of image noise between on 20m-FA10 and 20m-FA30. There was no significant
difference in noise between on 20m-FA10 (mean noise ± standard deviation, 1.33 ± 0.45) and on 20m-FA30
(1.35 ± 0.43), which suggests the image noise was not influenced when applying a 30˚ flip angle instead of a
10˚ flip angle.
doi:10.1371/journal.pone.0167701.g005
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short TR, longitudinal magnetization is not completely recovered. This effect is more obvious
for tissue with a longer T1 relaxation time such as hepatic malignant tumors without Gd-
EOB-DTPA uptake, but relatively vague for normal liver parenchyma with a shorter T1 relaxa-
tion time arising from adequate Gd-EOB-DTPA uptake. The difference of residual longitudi-
nal magnetization between hepatic malignant tumors and normal liver parenchyma is
amplified by using a higher FA. Thus, increasing the FA boosts T1-weighting and improves
the contrast between hepatic malignant tumors and surrounding liver parenchyma. Accord-
ingly, higher FA has been recommended to produce a greater lesion-to-liver CNR and
improve detection of FHLs [14, 16]. On the basis of this theoretical background, we attempted
to use a higher FA to increase CNR for HCC and reduce the delay time for HPI while main-
taining detection performance for HCC in patients with chronic hepatitis or cirrhosis.
In previous studies, lesion-to-liver contrast ratios or CNRs on HPI acquired using a higher
FA (30–35˚) were significantly better than those acquired using a lower FA (10–12˚) at each
delay time from 5 to 10 minutes [15, 16]. Another study showed that 5-min delayed transi-
tional phase imaging using a 30˚ FA (5m-FA30) had a higher lesion-to-liver CNR for HCCs
compared with 20m-FA10 [18]. However, most patients in that study had chronic hepatitis or
compensatory liver cirrhosis (Child-Pugh A) and only 4 out of 32 patients with HCC had
decompensated liver cirrhosis (Child-Pugh B or C) [18]. In addition, the CNR difference
between 5min-FA30 and 20m-FA10 was not analyzed according to the severity of cirrhosis
[18]. In advanced cirrhosis, lesion-to-liver CNR and liver parenchymal enhancement on HPI
decrease compared with normal liver or early stage cirrhosis because the number of function-
ing hepatocytes and the ability of hepatocytes to uptake Gd-EOB-DTPA deteriorate [20–22,
33, 34]. Several studies have found that liver parenchymal enhancement in patients with
Child-Pugh A cirrhosis gradually increases over time to 20 minutes after administration of
Table 3. Detection Sensitivity of Focal Hepatic Lesions for the Two Readers on 10-minute Delayed Hepatocyte Phase Imaging (HPI) using a 30˚
Flip Angle (10m-FA30), 20-minute Delayed HPI using a 10˚ Flip Angle (20m-FA10) or a 30˚ Flip Angle (20m-FA30).
Reader A Reader B
10m-FA30 20m-FA10 20m-FA30 10m-FA30 20m-FA10 20m-FA30
All All lesions (223) 94.6% a91.0% 93.7% 92.4% 89.2% 92.4%
Large (180) 95.0% a90.6% 95.0% 92.8% 88.9% 93.9%
Small (43) 93.0% 93.0% 88.4% 90.7% 90.7% 86.0%
HCC (168) 94.0% a89.3% 93.5% 91.7% 87.5% 92.3%
Benign (55) 96.4% 96.4% 94.5% 94.5% 94.5% 92.7%
Group A All lesions (171) 95.9% 95.3% 95.3% 94.2% 94.2% 94.2%
Large (131) 96.9% 96.2% 97.7% 95.4% 95.4% 96.9%
Small (40) 92.5% 92.5% 87.5% 90.0% 90.0% 85.0%
HCC (119) 95.8% 95.0% 95.8% 94.1% 94.1% 95.0%
Benign (52) 96.2% 96.2% 94.2% 94.2% 94.2% 92.3%
Group B All lesions (52) 96.2% a82.7% 94.2% 92.3% a78.8% 92.3%
Large (49) 95.9% a81.6% 93.9% 91.8% a77.6% 91.8%
HCC (49) 95.9% a81.6% 93.9% 91.8% a77.6% 91.8%
Data in parentheses = the number of focal hepatic lesions. Group A = patients with chronic hepatitis or compensated liver cirrhosis (Child-Pugh A). Group
B = patients with decompensated liver cirrhosis (Child-Pugh B or C). Large = focal hepatic lesions 10 mm or greater in short axis. Small = focal hepatic
lesions less than 10 mm in short axis.
a Bonferroni corrected p value (Bold) is lesser than significance threshold (p value < 0.025 = 0.05/2) when the McNemar test was applied between 10m-
FA30 and 20m-FA10 or 20m-FA30, but there was no significant difference in the detection sensitivity between 10m-FA30 and 20m-FA30. In group B,
statistical analysis for small lesions or benign lesions could not be performed because of the small number of lesions.
doi:10.1371/journal.pone.0167701.t003
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Gd-EOB-DTPA, whereas patients with Child-Pugh B or C cirrhosis do not have a stepwise
increase after the portal venous phase [20, 21]. This outcome suggests that waiting for 20 min-
utes to obtain HPI is not necessary in patients with advanced cirrhosis [22]. In our study, we
therefore divided the patients into group A with compensated liver disease group (chronic
hepatitis or Child-Pugh A cirrhosis) and group B with decompensated liver disease group
(Child-Pugh B or C cirrhosis) [23] and then compared the lesion-to-liver CNR for HCC and
the detection sensitivity for FHLs among the three HPIs within these subgroups.
In a previous study, patients with Child-Pugh A cirrhosis showed strong liver parenchymal
enhancement on 20-min delayed HPI that was not much different than in patients without
liver cirrhosis [21]. From this observation, we inferred that the impairment of hepatocyte func-
tion in early stage liver cirrhosis does not significantly change the lesion-to-liver contrast. In a
previous study of patients with normal liver function, 10m-FA30 showed a higher lesion-to-
liver CNR and similar detection sensitivity for metastatic tumors compared to 20m-FA10 [19].
In our study, 10m-FA30 had a higher lesion-to-liver CNR of HCCs and similar detection sen-
sitivity compared to 20m-FA10 for group A (patients with chronic hepatitis and compensated
liver cirrhosis), which was concordant with the findings of the previous study of patients with
normal liver function [19]. There was also no significant difference in lesion detection sensitiv-
ity between 10m-FA30 and 20m-FA30, although the CNR of 20m-FA30 was significantly
higher than that of 10m-FA30. Such results may suggest that for the detection of HCC in
patients with chronic hepatitis and compensated liver cirrhosis, 20-min delayed HPIs can be
replaced by 10m-FA30 with similar or better diagnostic performance, as it has a sufficiently
high CNR and detection sensitivity.
In advanced liver cirrhosis, liver parenchymal enhancement deteriorated on HPI compared
with normal liver or early stage cirrhosis [20–22, 33, 34]. Therefore, it has been suggested that
HPI after 20 minutes or more might be required for cirrhotic patients [34, 35]. However, sev-
eral studies have shown that patients with Child-Pugh B or C cirrhosis do not have an increase
in liver parenchymal enhancement after 8 or 10 minutes after Gd-EOB-DTPA administration
[21, 22]. The author proposed that waiting 20 minutes for HPI was not necessary, and that
HPI might be obtained within 10 or 15 minutes after contrast administration to reduce MR
examination time [22]. We obtained HPI after a delay of 10 minutes and applied a high FA of
30˚ at HPI. In group B (patients with decompensated liver cirrhosis), the CNR for HCC and
detection sensitivity for FHLs on 10m-FA30 were significantly superior to those on 20m-
FA10. There was no significant difference in lesion-to-liver CNR or detection sensitivity
between 10m-FA30 and 20m-FA30. Therefore, we suggest that in patients with decompen-
sated liver cirrhosis, 10m-FA30 may be better than 20m-FA10 or 20m-FA30, given the higher
or similar diagnostic performance and time savings of 10 minutes.
Although using a higher FA on HPI increases the CNR of the tumor in the liver, it also
enhances the energy deposition in the patient’s body by radiofrequency (RF) pulses, referred
to as the specific absorption rate (SAR). The SAR, which relates to field strength, transmitter-
coil type, RF power, duty cycle, and patient body size, is proportionate to the square of the
strength of the FA and the static magnetic field. Accordingly, increasing the FA from 10˚ to
30˚ leads to a nine-fold increase of the SAR [14], which is usually not a problem at 1.5 T. How-
ever, it can be a considerable increase for 3.0T MRI, where the baseline SAR is four-times
higher than that of 1.5 T MRI [14, 16]. In HPI using a higher FA, an increase of ghosting arti-
fact of the bile duct was reported in the previous study [12]. Although that reason is uncertain,
the ghosting artifact seems to be visually more apparent because of increased SI of the excreted
contrast in the biliary duct at imaging using a higher FA [12]. We observed that subcutaneous
fat was in-homogeneously suppressed at imaging with a higher FA, compared with a lower FA.
With specialized ‘Quick Fat-Sat’ of the VIBE sequence used in this study, linear ordering,
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which also is referred as rectangular ordering, is performed as long as the fat signal along the
echo train after one fat saturation pulse can be nulled in k-space center. When we increase FA,
there is a point where even a 180˚ fat saturation pulse will not be enough. In that case the
sequence switches to central ordering. It is a characteristic of the specific sequence (VIBE)
designed by a specific vendor for the fat suppression technique. Both of them are sequential
samplings of k-space and differ in the ordering within the echo train following a fat suppres-
sion pulse.
There were a number of limitations in this study. First, our study was retrospective and
there was a difference in the number of patients and HCCs between both groups. Nevertheless,
lesion-to-liver CNRs for each group were normally distributed and showed internally consis-
tent patterns. Second, in the quantitative analysis, smaller lesions are affected more by the par-
tial volume effect to measure SI using round or oval ROI. Therefore, after all HCCs were
classified into two groups by short-axis diameter, CNR for small HCCs (<10 mm in the short-
axis) was not measured and that for large HCCs (10 mm in the short-axis) was only calcu-
lated to minimize the partial volume artifacts. Detection sensitivity of FHLs was analyzed for
both small and large FHLs, regardless of short-axis diameter. Finally, a few cases of HCC (4
out of 161) had Gd-EOB-DTPA uptake on HPI that resulted in iso-intensity or hyperintensity
related to the background liver signal intensity. However, there was no difference in the statis-
tical results, even though the lesions were not included in qualitative and qualitative analyses.
Neither of the two readers detected 3 out of these 4 HCCs on HPI. HCCs with contrast uptake
on HPI could be detected using contrast-enhanced dynamic imaging, diffusion-weighted
imaging, and T2w imaging.
In conclusion, 10m-FA30 yielded diagnostic performance similar to or higher than 20m-
FA10 or 20m-FA30 in patients with both compensated or decompensated chronic liver dis-
ease. This finding indicates that 10m-FA30 can potentially replace 20-min delayed HPI,
regardless of patient liver function, and also reduce delay time by 10 minutes.
Supporting Information
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